BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

29 hedge funds and large institutions have $5.15M invested in Bellicum Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$123K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$755K
3
Citadel Advisors
3
Citadel Advisors
Florida
$203K
4
LPL Financial
4
LPL Financial
California
$63K
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$50K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
AFM
2
Anson Funds Management
Texas
$0
3
GCP
3
GSA Capital Partners
United Kingdom
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
26
GSA Capital Partners
United Kingdom
– -$235K -66,558 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$94K -26,631 Closed
Millennium Management
28
Millennium Management
New York
– -$57K -16,248 Closed
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
– -$56K -15,760 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– -$15K -4,336 Closed
AF
31
Allworth Financial
California
– -$1K -300 Closed
1
2